Press releases

(French) ADN tumoral circulant dans le sang : un nouveau biomarqueur du cancer

Press release | 19 Jun 2012 - 16h36 | By INSERM PRESS OFFICE
Cancer
Sorry, this press release is only available in French.
TO CITE THIS POST :
Press release – Inserm press room (French) ADN tumoral circulant dans le sang : un nouveau biomarqueur du cancer Link : https://presse.inserm.fr/en/french-adn-tumoral-circulant-dans-le-sang-un-nouveau-biomarqueur-du-cancer/1831/

Other contents In the same category :

Cancer Voir tout

communi

The Yin and Yang of Low-dose Irradiation on Hematopoiesis

A team of researchers from CEA, Inserm, and the Paris-Sud and Paris Diderot universities has shown that exposure to low doses of irradiation (0.02 Gy) leads of a loss of hematopoietic stem cell[1] (HSC) function. The team has also shown that irradiation ...
communi

Major advances in the diagnosis and treatment of allograft rejection

Prof. Alexander Loupy, Hospital Necker Children AP-HP and Prof. Carmen Lefaucheur, the Saint-Louis Hospital AP-HP and the University Paris Diderot in the Cardiovascular Research Center (Inserm / Paris Descartes University), showed, in an article published in the journal   New England Journal of Medicine September 20, ...
fermer
fermer
RSS Youtube